BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27302385)

  • 1. Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.
    Borstlap WA; Coeymans TJ; Tanis PJ; Marijnen CA; Cunningham C; Bemelman WA; Tuynman JB
    Br J Surg; 2016 Aug; 103(9):1105-16. PubMed ID: 27302385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
    van Oostendorp SE; Smits LJH; Vroom Y; Detering R; Heymans MW; Moons LMG; Tanis PJ; de Graaf EJR; Cunningham C; Denost Q; Kusters M; Tuynman JB
    Br J Surg; 2020 Dec; 107(13):1719-1730. PubMed ID: 32936943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit?
    Cutting JE; Hallam SE; Thomas MG; Messenger DE
    Colorectal Dis; 2018 Oct; 20(10):854-863. PubMed ID: 29992729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.
    Borstlap WA; Tanis PJ; Koedam TW; Marijnen CA; Cunningham C; Dekker E; van Leerdam ME; Meijer G; van Grieken N; Nagtegaal ID; Punt CJ; Dijkgraaf MG; De Wilt JH; Beets G; de Graaf EJ; van Geloven AA; Gerhards MF; van Westreenen HL; van de Ven AW; van Duijvendijk P; de Hingh IH; Leijtens JW; Sietses C; Spillenaar-Bilgen EJ; Vuylsteke RJ; Hoff C; Burger JW; van Grevenstein WM; Pronk A; Bosker RJ; Prins H; Smits AB; Bruin S; Zimmerman DD; Stassen LP; Dunker MS; Westerterp M; Coene PP; Stoot J; Bemelman WA; Tuynman JB
    BMC Cancer; 2016 Jul; 16():513. PubMed ID: 27439975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
    Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
    Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
    Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
    World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era.
    Peacock O; Waters PS; Bressel M; Lynch AC; Wakeman C; Eglinton T; Koh CE; Lee PJ; Austin KK; Warrier SK; Solomon MJ; Frizelle FA; Heriot AG
    Br J Surg; 2019 Nov; 106(12):1685-1696. PubMed ID: 31339561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.
    Jeong JU; Nam TK; Kim HR; Shim HJ; Kim YH; Yoon MS; Song JY; Ahn SJ; Chung WK
    Radiat Oncol; 2016 Sep; 11(1):114. PubMed ID: 27595767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
    van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
    J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
    [No Abstract]   [Full Text] [Related]  

  • 13. Local excision of T1 and T2 rectal cancer: proceed with caution.
    Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M
    Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
    Madbouly KM; Hussein AM; Abdelzaher E
    Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we
    Rombouts AJM; Al-Najami I; Abbott NL; Appelt A; Baatrup G; Bach S; Bhangu A; Garm Spindler KL; Gray R; Handley K; Kaur M; Kerkhof E; Kronborg CJ; Magill L; Marijnen CAM; Nagtegaal ID; Nyvang L; Peters FP; Pfeiffer P; Punt C; Quirke P; Sebag-Montefiore D; Teo M; West N; de Wilt JHW;
    BMJ Open; 2017 Dec; 7(12):e019474. PubMed ID: 29288190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Early Rectal Cancer Treatment Revisited.
    Stornes T; Wibe A; Nesbakken A; Myklebust TÅ; Endreseth BH
    Dis Colon Rectum; 2016 Jul; 59(7):623-9. PubMed ID: 27270514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature.
    Eid Y; Alves A; Lubrano J; Menahem B
    J Visc Surg; 2018 Dec; 155(6):445-452. PubMed ID: 29657063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transanal local excision for distal rectal cancer and incomplete response to neoadjuvant chemoradiation - does baseline staging matter?
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Coelho AQ; Figueiredo MN; Fernandez LM; Gama-Rodrigues J
    Dis Colon Rectum; 2014 Nov; 57(11):1253-9. PubMed ID: 25285691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches.
    Bach SP;
    Colorectal Dis; 2022 May; 24(5):639-651. PubMed ID: 35114057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.